Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chris Probert

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
European Journal of Gastroenterology & Hepatology|March 12, 2019
Comparative effectiveness of antitumour necrosis factor agents and vedolizumab in ulcerative colitisRebecca Davis, Paula McParland, Susanna Dodd, et al.
Trials|March 10, 2017
The use of randomisation-based efficacy estimators in non-inferiority trialsDavid Gillespie, Daniel Farewell, Peter Barrett-Lee, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|December 25, 2019
Faecal volatile organic compounds in preterm babies at risk of necrotising enterocolitis: the DOVE studyChris Probert, Rosemary Greenwood, Arno Mayor, et al.
Inflammatory Bowel Diseases|June 1, 2016
Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical UseSreedhar Subramanian, Rebecca Asher, William Weston, et al.
United European Gastroenterology Journal|June 26, 2024
Faecal volatile organic compounds differ according to inflammatory bowel disease sub-type, severity, and response to treatment in paediatric patientsSalma Belnour, Rachael Slater, Kukatharmini Tharmaratnam, et al.
Peerj|April 13, 2019
A longitudinal study of the faecal microbiome and metabolome of periparturient maresShebl E Salem, Rachael Hough, Chris Probert, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 1, 2024
A novel Monash Pouch diet in patients with an ileoanal pouch is tolerable and has favorable metabolic luminal effectsZaid S Ardalan, Chu K Yao, Kraig Green, et al.
Ebiomedicine|August 22, 2024
Microbiome-driven IBS metabotypes influence response to the low FODMAP diet: insights from the faecal volatomeThomas Edward Conley, Rachael Slater, Stephen Moss, et al.
Sensors (Basel, Switzerland)|August 10, 2024
Gas Chromatography-Sensor System Aids Diagnosis of Inflammatory Bowel Disease, and Separates Crohn's from Ulcerative Colitis, in ChildrenRachael Slater, Kukatharmini Tharmaratnam, Salma Belnour, et al.
British Journal of Hospital Medicine (London, England : 2005)|November 2, 2021
Recommendations for the optimal use of mesalazine in the management of patients with mild to moderate ulcerative colitisAyesha Akbar, Ian Arnott, Nicholas A Kennedy, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
European Journal of Gastroenterology & Hepatology|March 12, 2019
Comparative effectiveness of antitumour necrosis factor agents and vedolizumab in ulcerative colitisRebecca Davis, Paula McParland, Susanna Dodd, et al.
Trials|March 10, 2017
The use of randomisation-based efficacy estimators in non-inferiority trialsDavid Gillespie, Daniel Farewell, Peter Barrett-Lee, et al.
Archives of Disease in Childhood. Fetal and Neonatal Edition|December 25, 2019
Faecal volatile organic compounds in preterm babies at risk of necrotising enterocolitis: the DOVE studyChris Probert, Rosemary Greenwood, Arno Mayor, et al.
Inflammatory Bowel Diseases|June 1, 2016
Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical UseSreedhar Subramanian, Rebecca Asher, William Weston, et al.
United European Gastroenterology Journal|June 26, 2024
Faecal volatile organic compounds differ according to inflammatory bowel disease sub-type, severity, and response to treatment in paediatric patientsSalma Belnour, Rachael Slater, Kukatharmini Tharmaratnam, et al.
Peerj|April 13, 2019
A longitudinal study of the faecal microbiome and metabolome of periparturient maresShebl E Salem, Rachael Hough, Chris Probert, et al.
JGH Open : an Open Access Journal of Gastroenterology and Hepatology|January 1, 2024
A novel Monash Pouch diet in patients with an ileoanal pouch is tolerable and has favorable metabolic luminal effectsZaid S Ardalan, Chu K Yao, Kraig Green, et al.
Ebiomedicine|August 22, 2024
Microbiome-driven IBS metabotypes influence response to the low FODMAP diet: insights from the faecal volatomeThomas Edward Conley, Rachael Slater, Stephen Moss, et al.
Sensors (Basel, Switzerland)|August 10, 2024
Gas Chromatography-Sensor System Aids Diagnosis of Inflammatory Bowel Disease, and Separates Crohn's from Ulcerative Colitis, in ChildrenRachael Slater, Kukatharmini Tharmaratnam, Salma Belnour, et al.
British Journal of Hospital Medicine (London, England : 2005)|November 2, 2021
Recommendations for the optimal use of mesalazine in the management of patients with mild to moderate ulcerative colitisAyesha Akbar, Ian Arnott, Nicholas A Kennedy, et al.
Pageof 6